# SOFOSBUVIR
> **ANDA211353** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2022-01-27
## Drug
- **FDA Application Number:** ANDA211353
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SOFOSBUVIR
- **Generic name:** Sofosbuvir
- **Active ingredients:** SOFOSBUVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS USA INC
- **First approval:** 2022-01-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211353)
---
*AI Analytics · CC0 1.0*